Summary
The extent of long-term depletion of serotonin (5-HT) produced by 3, 4-methylenedioxymethamphetmaine (MDMA) was assessd in rats treated with the antioxidants sodium ascorbate or L-cysteine. There was a 30–35% reduction in the striatal concentration of 5-HT 7 days following a single injection of MDMA (20mg/kg, sc). MDMA had no significant effect on striatal concentrations of 5-HT in rats that had been treated with ascorbate (250mg/kg, ip) or cysteine (500mg/kg, ip) 30 min prior to and 5hrs following the administration of MDMA. Treatment with ascorbate or cysteine did not alter the accumulation of MDMA in brain as determined by in vivo microdialysis. Moreover, neither ascorbate nor cysteine altered the stimulation of dopamine release elicited by MDMA. These data are supportive of the view that MDMA-induced toxicity of 5-HT neurons may be related to the production of free radicals and subsequent oxidative damage.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Battaglia G, Yeh SY, De Souza E (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29: 269–274
Brodkin JA, Malyala A, Nash JF (1993) Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 45: 647–653
Cadet JL, Ladenheim B, Baum I, Carlson E, Epstein C (1994a) CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetaine (MDMA). Brain Res 655: 259–262
Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C (1994b) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc Superoxide dismustase transgenic mice. J Neurochem 62: 380–383
Chiueh CC, Miyake H, Peng M-T (1993) Role of dopamine autoxidation, hydroyxl radical generation and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv Neurol 60: 251–258
Colado M, Green AR (1995) The spin trap agent alpha-phenyl-N-tert-butyl nitrone prevents “ecstasy”-induced neurodegeneration of 5-hydroxytryptamine neurons. Eur J Pharmacol 280: 343–346
Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987) Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241: 338–345
De Vito M, Wagner GL (1989) Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28: 1145–1150
Filloux F, Townsend JJ (1993) Pre and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 119: 79–88
Floyd RA, Watson JJ, Wong PK (1984) Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection phenol and salicylate hydroxylation products. J Biochem Biophys Methods 190: 221–235
Gibb JW, Johnson M, Hanson GR (1990) Neurochemical basis of neurotoxicity. Neurotoxicology 11: 317–322
Giovanni A, Liang L, Hastings TG, Zigmond M (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 64: 1819–1825
Gudelsky G, Yamamoto B (1994) MDMA increases the extracellular concentration of 2,3-dihydroxybenzoic acid in the striatum: evidence for increased hydroxyl radical formation. Soc Neuroci Abstr 20: 343
Gudelsky G, Yamamoto B, Nash JF (1994) Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 agonists. Eur J Pharmacol 264: 325–330
Gutteridge J, Halliwell B (1990) The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15: 129–135
Hastings TG, Zigmond MJ (1994) Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic and glutathione. J Neurochem 63: 1126–1132
Hiramatsu M, Kumagai Y, Unger S, Cho A (1990) Metabolism of methylenedioxymethamphetmine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J Pharmacol Exp Ther 254: 521–528
Hirata H, Ladenheim B, Rothman R, Epstien C, Cadet JL (1995) Methampehtamine-induced serotoinin neurotoxicity is mediated by Superoxide radicals. Brain Res 677: 345–347
Invernizzi R, Fracesso C, Caccia S, Di Clemente A, Garattini S, Samanin R (1989) Effect of L-cysteine on the long-term depletion of brain indoles caused by p-chloroamphetamine and d-fenfluramine in rats. Relation to brain drug concentrations. Eur J Pharmacol 163: 77–83
Michel PP, Hefti F (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 26: 428–435
Nash JF (1990) Ketanserin pretreatment blocks MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis. Life Sci 47: 2401–2408
O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocyto-chemical evidence for neurotoxicity. J Neurosci 8: 2788–2803
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd ed. Academic Press, New York
Rosenberg PA (1988) Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci 8: 3887–2894
Scanzello CR, Hatzidimitriou G, Martello AL, Katz GL, Ricaurte GA (1993) Serotonergic recovery after (±) 3,4-(methylenedioxy)methamphetamine injury: observations in rats. J Pharmacol Exp Ther 264: 1484–1492
Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240: 1–7
Schmidt CJ, Taylor VL, Abbate G, Nieduzak T (1991) 5-HT2 Antagonists stereoselectively prevent the neurotoxicity of 3,4-methlenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa. J Pharmacol Exp Ther 256: 230–235
Schmidt CJ, Sullivan CK, Fadayel GM (1994) Blockade of striatal 5-hydroxytryptamine-2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. J Neurochem 62: 1382–1389
Sprague J, Nichols DE (1995) The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and longterm serotonergic deficits. J Pharmacol Exp Ther 273: 667–673
Steranka L, Rhind A (1987) Effect of cysteine on the persistent depletion of brain monoamines by amphetamine, p-chloroamphetamine and MPTP. Eur J Pharmacol 133: 191–197
Stone DM, Merchant KM, Hanson GR, Gibb JW (1987) Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacol 26: 1677–1683
Stone DM, Johnson M, Hanson GR, Gibb JW (1988) Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 247: 79–87
Stone DM, Hanson GR, Gibb JW (1989) In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine. J Neurochem 53: 572–581
Wagner G, Carelli R, Jarvis M (1985) Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res Comm Chem Path Pharm 47: 221–228
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gudelsky, G.A. Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin. J. Neural Transmission 103, 1397–1404 (1996). https://doi.org/10.1007/BF01271253
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01271253